Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0000892251-23-000201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-18 | 2023-12-14+ | MEDP | BURWIG SUSAN E | EVP, Ops | S - Sale | $303.96 | -12.4K | 17.3K | -42% | -$3.77M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | S | D | 2,009 | $303.00 | 15,283 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-14 | S | D | 10,391 | $304.15 | 17,292 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $303.00 to $305.455. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |